Valuation: Abbott Laboratories

Capitalization 200B 191B 177B 157B 284B 17,000B 314B 2,200B 812B 6,981B 752B 736B 30,463B P/E ratio 2024 *
33.7x
P/E ratio 2025 * 29.1x
Enterprise value 207B 197B 182B 162B 293B 17,548B 325B 2,271B 838B 7,205B 776B 760B 31,444B EV / Sales 2024 *
4.92x
EV / Sales 2025 * 4.57x
Free-Float
-
Yield 2024 *
1.91%
Yield 2025 * 2.02%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.52%
1 week-0.68%
Current month-2.75%
1 month-0.93%
3 months-1.37%
6 months+7.45%
Current year+4.93%
More quotes
1 week
113.85
Extreme 113.85
116.39
1 month
113.85
Extreme 113.85
120.53
Current year
99.71
Extreme 99.71
121.64
1 year
99.71
Extreme 99.71
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Director TitleAgeSince
Chief Executive Officer 50 2020-03-30
Director of Finance/CFO 51 2023-08-31
Chief Tech/Sci/R&D Officer - 2020-02-29
Manager TitleAgeSince
Director/Board Member 73 2008-10-09
Director/Board Member 62 2011-12-08
Director/Board Member 65 2011-12-08
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.52%-0.68%+10.52%-14.04%200B
-0.45%-2.49%+5.33%-25.66%107B
-0.70%+0.08%-4.67%-9.61%64.02B
-0.34%+2.16%+20.07%+14.13%46.64B
-1.46%-5.21%+17.48%+92.49%45.81B
+1.28%-1.85%-32.11%-43.93%31.02B
+0.46%-1.90%+27.84%+28.57%29.46B
-0.90%-0.81%-6.71%-26.02%23.12B
-0.98%-2.11%-7.59%-12.92%21.58B
-0.65%-1.12%+6.84%-6.78%21.15B
Average -0.32%-1.56%+3.70%-0.38% 59.03B
Weighted average by Cap. -0.13%-1.69%+6.38%-4.79%
See all sector performances

Financials

2024 *2025 *
Net sales 42B 39.97B 37.04B 32.95B 59.48B 3,564B 65.92B 461B 170B 1,463B 158B 154B 6,386B 44.98B 42.81B 39.67B 35.28B 63.7B 3,817B 70.59B 494B 182B 1,567B 169B 165B 6,839B
Net income 5.94B 5.65B 5.24B 4.66B 8.41B 504B 9.32B 65.22B 24.07B 207B 22.29B 21.81B 903B 6.85B 6.52B 6.04B 5.38B 9.7B 581B 10.75B 75.25B 27.78B 239B 25.72B 25.17B 1,042B
Net Debt 6.45B 6.14B 5.69B 5.06B 9.14B 547B 10.13B 70.85B 26.16B 225B 24.22B 23.7B 981B 5.08B 4.84B 4.49B 3.99B 7.2B 432B 7.98B 55.85B 20.62B 177B 19.09B 18.68B 773B
More financial data * Estimated data
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Employees
114,000
More about the company
Date Price Change Volume
24-12-10 115.50 $ +0.52% 4,072,098
24-12-09 114.90 $ -0.61% 4,868,047
24-12-06 115.60 $ +0.01% 5,300,680
24-12-05 115.59 $ -0.33% 3,269,799
24-12-04 115.97 $ -0.28% 3,557,185

Delayed Quote Nyse, December 10, 2024 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
surperformance-ratings-light-chart ABBOTT-LABORATORIESMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
115.50USD
Average target price
129.87USD
Spread / Average Target
+12.44%
Consensus

Quarterly revenue - Rate of surprise